Positive surgical margins after radical prostatectomy: a systematic review and contemporary update

Standard

Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. / Yossepowitch, Ofer; Briganti, Alberto; Eastham, James A; Epstein, Jonathan; Graefen, Markus; Montironi, Rodolfo; Touijer, Karim.

In: EUR UROL, Vol. 65, No. 2, 01.02.2014, p. 303-313.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Yossepowitch, O, Briganti, A, Eastham, JA, Epstein, J, Graefen, M, Montironi, R & Touijer, K 2014, 'Positive surgical margins after radical prostatectomy: a systematic review and contemporary update', EUR UROL, vol. 65, no. 2, pp. 303-313. https://doi.org/10.1016/j.eururo.2013.07.039

APA

Yossepowitch, O., Briganti, A., Eastham, J. A., Epstein, J., Graefen, M., Montironi, R., & Touijer, K. (2014). Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. EUR UROL, 65(2), 303-313. https://doi.org/10.1016/j.eururo.2013.07.039

Vancouver

Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. EUR UROL. 2014 Feb 1;65(2):303-313. https://doi.org/10.1016/j.eururo.2013.07.039

Bibtex

@article{46a263e27c784a328eeed8a4178a847e,
title = "Positive surgical margins after radical prostatectomy: a systematic review and contemporary update",
abstract = "CONTEXT: The clinical significance of positive surgical margins (PSMs) in radical prostatectomy (RP) specimens and the management of affected patients remain unclear.OBJECTIVE: To address pitfalls in the pathologic interpretation of margin status; provide an update on the incidence, predictors, and long-term oncologic implications of PSMs in the era of robot-assisted laparoscopic RP (RALRP); and suggest a practical evidence-based approach to patient management.EVIDENCE ACQUISITION: A systematic review of the literature was performed in April 2013 using Medline/PubMed, Web of Science, and Scopus databases and the Cochrane Database of Systematic Reviews. Studies focusing on PSMs in RP pertinent to the objectives of this review were included. Particular attention was paid to publications within the last 5 yr and those concerning RALRP.EVIDENCE SYNTHESIS: A total of 74 publications were retrieved. Standardized measures to overcome variability in the pathologic interpretation of surgical margins have recently been established by the International Society of Urological Pathology. The average rate of PSMs in contemporary RALRP series is 15% (range: 6.5-32%), which is higher in men with a more advanced pathologic stage and equivalent to the rate reported in prior open and laparoscopic prostatectomy series. The likelihood of PSMs is strongly influenced by the surgeon's experience irrespective of the surgical approach. Technical modifications using the robotic platform and the role of frozen-section analysis to reduce the margin positivity rate continue to evolve. Positive margins are associated with a twofold increased hazard of biochemical relapse, but their association with more robust clinical end points is controversial. Level 1 evidence suggests that adjuvant radiation therapy (RT) may favorably affect prostate-specific antigen recurrence rates, but whether the therapy also affects systemic progression, prostate cancer-specific mortality, and overall survival remains debatable.CONCLUSIONS: Although positive margins in prostate cancer are considered an adverse oncologic outcome, their long-term impact on survival is highly variable and largely influenced by other risk modifiers. Adjuvant RT appears to be effective, but further study is required to determine whether early salvage RT is an equivalent alternative.",
keywords = "Disease Progression, Frozen Sections, Humans, Laparoscopy, Male, Neoplasm Recurrence, Local, Neoplasm, Residual, Predictive Value of Tests, Prostatectomy, Prostatic Neoplasms, Radiotherapy, Adjuvant, Risk Factors, Salvage Therapy, Time Factors, Treatment Outcome",
author = "Ofer Yossepowitch and Alberto Briganti and Eastham, {James A} and Jonathan Epstein and Markus Graefen and Rodolfo Montironi and Karim Touijer",
note = "Copyright {\textcopyright} 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.",
year = "2014",
month = feb,
day = "1",
doi = "10.1016/j.eururo.2013.07.039",
language = "English",
volume = "65",
pages = "303--313",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Positive surgical margins after radical prostatectomy: a systematic review and contemporary update

AU - Yossepowitch, Ofer

AU - Briganti, Alberto

AU - Eastham, James A

AU - Epstein, Jonathan

AU - Graefen, Markus

AU - Montironi, Rodolfo

AU - Touijer, Karim

N1 - Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - CONTEXT: The clinical significance of positive surgical margins (PSMs) in radical prostatectomy (RP) specimens and the management of affected patients remain unclear.OBJECTIVE: To address pitfalls in the pathologic interpretation of margin status; provide an update on the incidence, predictors, and long-term oncologic implications of PSMs in the era of robot-assisted laparoscopic RP (RALRP); and suggest a practical evidence-based approach to patient management.EVIDENCE ACQUISITION: A systematic review of the literature was performed in April 2013 using Medline/PubMed, Web of Science, and Scopus databases and the Cochrane Database of Systematic Reviews. Studies focusing on PSMs in RP pertinent to the objectives of this review were included. Particular attention was paid to publications within the last 5 yr and those concerning RALRP.EVIDENCE SYNTHESIS: A total of 74 publications were retrieved. Standardized measures to overcome variability in the pathologic interpretation of surgical margins have recently been established by the International Society of Urological Pathology. The average rate of PSMs in contemporary RALRP series is 15% (range: 6.5-32%), which is higher in men with a more advanced pathologic stage and equivalent to the rate reported in prior open and laparoscopic prostatectomy series. The likelihood of PSMs is strongly influenced by the surgeon's experience irrespective of the surgical approach. Technical modifications using the robotic platform and the role of frozen-section analysis to reduce the margin positivity rate continue to evolve. Positive margins are associated with a twofold increased hazard of biochemical relapse, but their association with more robust clinical end points is controversial. Level 1 evidence suggests that adjuvant radiation therapy (RT) may favorably affect prostate-specific antigen recurrence rates, but whether the therapy also affects systemic progression, prostate cancer-specific mortality, and overall survival remains debatable.CONCLUSIONS: Although positive margins in prostate cancer are considered an adverse oncologic outcome, their long-term impact on survival is highly variable and largely influenced by other risk modifiers. Adjuvant RT appears to be effective, but further study is required to determine whether early salvage RT is an equivalent alternative.

AB - CONTEXT: The clinical significance of positive surgical margins (PSMs) in radical prostatectomy (RP) specimens and the management of affected patients remain unclear.OBJECTIVE: To address pitfalls in the pathologic interpretation of margin status; provide an update on the incidence, predictors, and long-term oncologic implications of PSMs in the era of robot-assisted laparoscopic RP (RALRP); and suggest a practical evidence-based approach to patient management.EVIDENCE ACQUISITION: A systematic review of the literature was performed in April 2013 using Medline/PubMed, Web of Science, and Scopus databases and the Cochrane Database of Systematic Reviews. Studies focusing on PSMs in RP pertinent to the objectives of this review were included. Particular attention was paid to publications within the last 5 yr and those concerning RALRP.EVIDENCE SYNTHESIS: A total of 74 publications were retrieved. Standardized measures to overcome variability in the pathologic interpretation of surgical margins have recently been established by the International Society of Urological Pathology. The average rate of PSMs in contemporary RALRP series is 15% (range: 6.5-32%), which is higher in men with a more advanced pathologic stage and equivalent to the rate reported in prior open and laparoscopic prostatectomy series. The likelihood of PSMs is strongly influenced by the surgeon's experience irrespective of the surgical approach. Technical modifications using the robotic platform and the role of frozen-section analysis to reduce the margin positivity rate continue to evolve. Positive margins are associated with a twofold increased hazard of biochemical relapse, but their association with more robust clinical end points is controversial. Level 1 evidence suggests that adjuvant radiation therapy (RT) may favorably affect prostate-specific antigen recurrence rates, but whether the therapy also affects systemic progression, prostate cancer-specific mortality, and overall survival remains debatable.CONCLUSIONS: Although positive margins in prostate cancer are considered an adverse oncologic outcome, their long-term impact on survival is highly variable and largely influenced by other risk modifiers. Adjuvant RT appears to be effective, but further study is required to determine whether early salvage RT is an equivalent alternative.

KW - Disease Progression

KW - Frozen Sections

KW - Humans

KW - Laparoscopy

KW - Male

KW - Neoplasm Recurrence, Local

KW - Neoplasm, Residual

KW - Predictive Value of Tests

KW - Prostatectomy

KW - Prostatic Neoplasms

KW - Radiotherapy, Adjuvant

KW - Risk Factors

KW - Salvage Therapy

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1016/j.eururo.2013.07.039

DO - 10.1016/j.eururo.2013.07.039

M3 - SCORING: Journal article

C2 - 23932439

VL - 65

SP - 303

EP - 313

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 2

ER -